REZUROCK
Live / Registered — Registered (as of 22 Feb 2022)
What this means for you
Registered since 22 Feb 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88401751
- Registration number
- 6654082
- Mark type
- Stylized text
- Filed
- 25 Apr 2019
- Published for opposition
- 25 Feb 2020
- Registered
- 22 Feb 2022
- Attorney of record
- Michael J. Leonard
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals and pharmaceutical preparations, namely, anti-inflammatories; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical products for the prevention and treatment of respiratory diseases
Owner
- Kadmon Pharmaceuticals, LLC, Warrendale, PA, US
- Kadmon Pharmaceuticals, LLC, Warrendale, PA, US
- Kadmon Pharmaceuticals, LLC, Warrendale, PA, US
Prosecution history
- 22 Feb 2022 — REGISTERED-PRINCIPAL REGISTER
- 20 Jan 2022 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 19 Jan 2022 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 14 Sept 2021 — STATEMENT OF USE PROCESSING COMPLETE
- 02 Sept 2021 — USE AMENDMENT FILED
- 13 Sept 2021 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 02 Sept 2021 — TEAS STATEMENT OF USE RECEIVED
- 22 Apr 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 20 Apr 2021 — SOU EXTENSION 2 GRANTED
- 20 Apr 2021 — SOU EXTENSION 2 FILED
- 20 Apr 2021 — SOU TEAS EXTENSION RECEIVED
- 23 Oct 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 21 Oct 2020 — SOU EXTENSION 1 GRANTED
- 21 Oct 2020 — SOU EXTENSION 1 FILED
- 21 Oct 2020 — SOU TEAS EXTENSION RECEIVED